Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls

Journal of Clinical Psychiatry

Volumn 71, Issue 8, 2010, Pages 976-981

  Ronaldson, Kathlyn J ^a   Taylor, Andrew J ^b   Fitzgerald, Paul B ^b   Topliss, Duncan J ^b   Elsik, Maros ^a   McNeil, John J ^a  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CLOZAPINE; TROPONIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; EOSINOPHILIA; FEMALE; HEART DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LONG TERM CARE; MALE; MEDICAL RECORD REVIEW; MORTALITY; MYOCARDITIS; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; TACHYCARDIA;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTIPSYCHOTIC AGENTS; AUSTRALIA; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CLOZAPINE; ECHOCARDIOGRAPHY; EOSINOPHILIA; FEMALE; FEVER; GATED BLOOD-POOL IMAGING; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; TACHYCARDIA; TROPONIN;

EID: 77956008256     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05024yel     Document Type: Article

References (25)

1. Kilian JG, Kerr K, Lawrence C, et al. Myocarditis and cardiomyopathy associated with clozapine. Lancet. 1999;354(9193):1841-1845.
2. Coulter DM, Bate A, Meyboom RH, et al. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. BMJ. 2001;322(7296):1207-1209.
3. Reinders J, Parsonage W, Lange D, et al. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service. Aust N Z J Psychiatry. 2004;38(11-12):915-922. PubMed doi:10.1/j.140-1614.204.01481.x (Pubitemid 40028895)
4. Tirupati S. Clozapine and heart in the Hunter region. Aust N Z J Psychiatry. 2006;40(1):97.
5. Freedman R. The choice of antipsychotic drugs for schizophrenia. N Engl J Med. 2005;353(12):1286-1288.
6. Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373(9657):31-41.
7. Bandelow B, Degner D, Kreusch U, et al. Myocarditis under therapy with clozapine. Schizophr Res. 1995;17(3):293-294.
8. Reid P. Clozapine rechallenge after myocarditis. Aust N Z J Psychiatry. 2001;35(2):249.
9. Annamraju S, Sheitman B, Saik S, et al. Early recognition of clozapine-induced myocarditis. J Clin Psychopharmacol. 2007;27(5):479-483.
10. Pieroni M, Cavallaro R, Chimenti C, et al. Clozapine-induced hypersensitivity myocarditis. Chest. 2004;126(5):1703-1705.
11. Kakar P, Millar-Craig M, Kamaruddin H, et al. Clozapine induced myocarditis: a rare but fatal complication. lnt. J Cardiol. 2006;112(2):e5-e6.
12. Fineschi V, Neri M, Riezzo I, et al. Sudden cardiac death due to hypersensitivity myocarditis during clozapine treatment. Int J Legal Med. 2004;118(5):307-309.
13. Merrill DB, Ahmari SE, Bradford J-ME, et al. Myocarditis during clozapine treatment. Am J Psychiatry. 2006;163(2):204-208.
14. Varambally S, Howpage P. Acute myocarditis associated with clozapine. Australas Psychiatry. 2007;15(4):343-346.
15. Belloni E, De Cobelli F, Esposito A, et al. Myocarditis associated with clozapine studied by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2007;9(3):591-593. PubMed doi:10.1080/1097640601015458 (Pubitemid 46399015)
16. Rathore S, Masani ND, Callaghan PO. Clozapine-induced effuso-constrictive pericarditis: case report and review of the literature. Cardiology. 2007;108(3):183-185.
17. Haas SJ, Hill R, Krum H, et al. Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003. Drug Saf. 2007;30(1):47-57.
18. Hägg S, Spigset O, Bate A, et al. Myocarditis related to clozapine treatment. J Clin Psychopharmacol. 2001;21(4):382-388.
19. Degner D, Bleich S, Grohmann R, et al. Myocarditis associated with clozapine treatment. Aust N Z J Psychiatry. 2000;34(5):880.
20. La Grenade L, Graham D, Trontell A. Myocarditis and cardiomyopathy associated with clozapine use in the United States. N Engl J Med. 2001; 345(3):224-225.
21. Hill GR, Harrison-Woolrych M. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme. N Z Med J. 2008;121(1283):68-75.
22. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation. 1998;97(18):1802-1809. PubMed (Pubitemid 28213624)
23. Berk M, Fitzsimons J, Lambert T, et al. Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS Drugs. 2007;21(2): 117-127.
24. Devarajan S, Kutcher SP, Dursun SM. Clozapine and sudden death. Lancet. 2000;355(9206):841, author reply 843.
25. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360(3):225-235.